ConductScience.org, home

Paper4091785

Influence of dipyridamole on infarct size and on cardiac nucleoside content following coronary occlusion in the dog.

Matsuoka H and 2 others. Basic Res Cardiol, 1985. Cited by 9 papers, by iCite.

Cite this record

ConductScience Library. Influence of dipyridamole on infarct size and on cardiac nucleoside content following coronary occlusion in the dog. Papers, record 4091785. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4091785

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Influence of dipyridamole on infarct size and on cardiac nucleoside content following coronary occlusion in the dog.
PubMed
Journal
Basic Res Cardiol
PubMed
Year
1985
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
9
iCite
Relative citation ratio, by iCite
0.32
iCite
Revised in PubMed
2019-09-03
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Matsuoka HH
2Henrichs KJK J
3Schaper WW

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AdenosineMajor topic
DipyridamoleMajor topic
Myocardial InfarctionMajor topic
Animals
Chromatography, High Pressure Liquid
Coronary Disease
Dogs
Female
Hemodynamics
Inosine
Male
Myocardium
Phosphocreatine

Source PubMed

Download CSV of topics

References14

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
16254686The role of adenosine in the regulation of coronary blood flow.Circ Res1980https://conductscience.org/library/papers/6254686PubMed
213628477[Pharmacological properties of a new coronary dilator substance 2, 6-bis(diethanolamino)-4, 8-dipiperidino-pyrimido[5,4-d]pyrimidine].Arzneimittelforschung1959https://conductscience.org/library/papers/13628477PubMed
36604525The control of adenosine concentration in polymorphonuclear leucocytes, cultured heart cells and isolated perfused heart from the rat.Biochem J1983https://conductscience.org/library/papers/6604525PubMed
45520352Influence of dipyridamol (Persantin) on myocardial adenosine metabolism.J Mol Cell Cardiol1970https://conductscience.org/library/papers/5520352PubMed
55541108Adenosine and adenine nucleotides as possible mediators of cardiac and skeletal muscle blood flow regulation.Circ Res1971https://conductscience.org/library/papers/5541108PubMed
65347963Uptake and deamination of adenosine by blood. Species differences, effect of pH, ions, temperature and metabolic inhibitors.Biochim Biophys Acta1969https://conductscience.org/library/papers/5347963PubMed
77285306Salvage of ischemic myocardium by dipyridamole in the conscious dog.Circulation1981https://conductscience.org/library/papers/7285306PubMed
81168469Adenosine uptake by erythrocytes of man, rat and guinea-pig and its inhibition by hexobendine and dipyridamole.Biochem Pharmacol1975https://conductscience.org/library/papers/1168469PubMed
95782714Potentiation of adenosine activity by low oral doses of lidoflazine.Nature1969https://conductscience.org/library/papers/5782714PubMed
107124399The prophylactic effect of dipyridamole on the size of myocardial infarction following coronary artery occlusion.Acta Pathol Microbiol Immunol Scand A1982https://conductscience.org/library/papers/7124399PubMed
117351049Effectiveness of dipyridamole in reducing the size of experimental myocardial infarction.Circulation1980https://conductscience.org/library/papers/7351049PubMed
124606569Functional significance of the coronary collateral circulation. A review.Am J Pathol1974https://conductscience.org/library/papers/4606569PubMed
13632362A comparison of four potential agents for reducing necrosis after prolonged coronary occlusion.J Clin Pharmacol1978https://conductscience.org/library/papers/632362PubMed
14475727Experimental occlusion of two small coronary arteries in the same heart. A new validation method for infarct size manipulation.Basic Res Cardiol1979https://conductscience.org/library/papers/475727PubMed

Download CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.

PMIDTitleJournalYearIn PapersSource
30744423Ticagrelor Does Not Protect Isolated Rat Hearts, Thus Clouding Its Proposed Cardioprotective Role Through ENT 1 in Heart Tissue.J Cardiovasc Pharmacol Ther2019https://conductscience.org/library/papers/30744423PubMed
9546646Effects of nucleoside transport inhibitors and adenine/ribose supply on ATP concentration and adenosine production in cardiac myocytes.Mol Cell Biochem1998https://conductscience.org/library/papers/9546646PubMed
2770708Inhibitors of adenosine catabolism improve recovery of dog myocardium after ischemia.Mol Cell Biochem1989https://conductscience.org/library/papers/2770708PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/4091785

GET https://conductscience.org/api/papers/v1/4091785/authors